MX354325B - Método para preparar conjugados glucïdicos de glicopéptidos antigénicos múltiples. - Google Patents

Método para preparar conjugados glucïdicos de glicopéptidos antigénicos múltiples.

Info

Publication number
MX354325B
MX354325B MX2013010618A MX2013010618A MX354325B MX 354325 B MX354325 B MX 354325B MX 2013010618 A MX2013010618 A MX 2013010618A MX 2013010618 A MX2013010618 A MX 2013010618A MX 354325 B MX354325 B MX 354325B
Authority
MX
Mexico
Prior art keywords
preparing
gluctidic
glicopeptides
conjugates
multiple antigenic
Prior art date
Application number
MX2013010618A
Other languages
English (en)
Other versions
MX2013010618A (es
Inventor
Bay Sylvie
Leclerc Claude
Lo-Man Richard
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of MX2013010618A publication Critical patent/MX2013010618A/es
Publication of MX354325B publication Critical patent/MX354325B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Container Filling Or Packaging Operations (AREA)

Abstract

La presente invención se refiere a un método para preparar conjugado glucídico de epitope de célula T de la fórmula (I): M(T-B)n (I). Un conjugado glucídico de epitope de célula T de la fórmula (II) M(T-BPr)n.
MX2013010618A 2011-03-17 2012-03-16 Método para preparar conjugados glucïdicos de glicopéptidos antigénicos múltiples. MX354325B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11290138A EP2500033A1 (en) 2011-03-17 2011-03-17 Method for preparing muliple antigen glycopeptide carbohydrate conjugates
PCT/IB2012/051285 WO2012123926A1 (en) 2011-03-17 2012-03-16 Method for preparing multiple antigen glycopeptide carbohydrate conjugates

Publications (2)

Publication Number Publication Date
MX2013010618A MX2013010618A (es) 2014-04-14
MX354325B true MX354325B (es) 2018-02-26

Family

ID=44512239

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010618A MX354325B (es) 2011-03-17 2012-03-16 Método para preparar conjugados glucïdicos de glicopéptidos antigénicos múltiples.

Country Status (16)

Country Link
US (2) US20140378652A9 (es)
EP (2) EP2500033A1 (es)
JP (1) JP6006244B2 (es)
KR (1) KR20140048107A (es)
CN (1) CN103732246B (es)
AU (1) AU2012227940A1 (es)
BR (1) BR112013023599B1 (es)
CA (1) CA2828688C (es)
DK (1) DK2686009T3 (es)
EA (1) EA201391202A1 (es)
ES (1) ES2537180T3 (es)
IL (1) IL228384A0 (es)
MX (1) MX354325B (es)
SG (1) SG193433A1 (es)
WO (1) WO2012123926A1 (es)
ZA (1) ZA201306219B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11780934B2 (en) 2016-02-05 2023-10-10 Institut Pasteur Use of inhibitors of ADAM12 as adjuvants in tumor therapies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105503A (en) 1992-04-28 1999-05-09 Astra Ab Carbon peptide couplets capable of eliciting an immune response of T cells
US6410690B1 (en) * 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies
EP0969873B1 (en) 1997-03-27 2006-06-07 Institut Pasteur Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
US6676946B2 (en) * 1997-03-27 2004-01-13 Institut Pasteur Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof
WO1998046246A1 (en) * 1997-04-16 1998-10-22 Sloan-Kettering Institute For Cancer Research α-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF

Also Published As

Publication number Publication date
JP2014510083A (ja) 2014-04-24
ES2537180T3 (es) 2015-06-03
ZA201306219B (en) 2014-05-28
JP6006244B2 (ja) 2016-10-12
IL228384A0 (en) 2013-12-31
CA2828688C (en) 2021-08-03
US20170283466A1 (en) 2017-10-05
EA201391202A1 (ru) 2014-03-31
EP2500033A1 (en) 2012-09-19
CA2828688A1 (en) 2012-09-20
WO2012123926A1 (en) 2012-09-20
SG193433A1 (en) 2013-10-30
US20140171618A1 (en) 2014-06-19
US10899799B2 (en) 2021-01-26
CN103732246A (zh) 2014-04-16
BR112013023599A2 (pt) 2019-05-07
AU2012227940A1 (en) 2013-09-05
DK2686009T3 (da) 2015-06-15
MX2013010618A (es) 2014-04-14
BR112013023599B1 (pt) 2023-01-10
EP2686009B1 (en) 2015-04-29
EP2686009A1 (en) 2014-01-22
US20140378652A9 (en) 2014-12-25
CN103732246B (zh) 2017-06-30
KR20140048107A (ko) 2014-04-23

Similar Documents

Publication Publication Date Title
EA201291154A1 (ru) Выбор дозы синтетических наноносителей с адъювантами
GB201103836D0 (en) Conjugation process
CL2016001732A1 (es) Métodos sintéticos para compuestos espiro-oxoindol (div. sol. 3633-13).
MX338078B (es) Cristales de anticuerpos anti-esclerostina y formulaciones de los mismos.
ECSP12012221A (es) Anticuerpos anti-cd40
CR20120184A (es) Anticuerpos monoclonales frente a progastrina y su usos
EP2429585A4 (en) VACCINE IMMUNOTHERAPY
UY34456A (es) Anticuerpos anti-il-36r
UY34411A (es) Inmunoenlazantes dirigidos contra esclerostina
CU24354B1 (es) Procedimiento de obtención de derivados de tetrafluoropropilmorfolina
IN2014MN02574A (es)
CR20130071A (es) Anticuerpos para el receptor del factor de crecimiento epidérmico 3 (her 3)
MX391043B (es) Formulaciones de anticuerpo y metodos.
CR20130539A (es) Triazolopiridinas
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
CR20140306A (es) Fluormetil -5,6-dihidro-4h-[1,3] oxazinas
DK3564378T3 (da) Immunogen sammensætning
BR122018074319B8 (pt) Método para preparar um composto de fórmula 14
MX2013007567A (es) Procedimiento para preparar poliestereteroles.
CR20140124A (es) Metabolitos de transclomifeno y usos de los mismos
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
NI201200195A (es) Procedimiento de preparación de la sal de l - arginina de perindoprilo
EA201300733A1 (ru) Рекомбинантные микобактерии в качестве вакцины
UY33864A (es) Novedoso Derivado Cristalino de Oxazina
UY34403A (es) Preparación de liberación sostenida

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: INSTITUT PASTEUR

FG Grant or registration